文摘
A clinical practice guideline for early stage Hodgkin lymphoma is proposed. The recommendations, based on a systematic review, have been reviewed by an external panel. Evidence quality was evaluated with the Cochrane Risk of Bias tool and we used GRADE. Combined modality therapy or chemotherapy alone are options for early-stage Hodgkin lymphoma. PET scanning was not considered a good tool to identify patients for whom IFRT could be omitted.